HPS6

HPS6 biogenesis of lysosomal organelles complex 2 subunit 3, the group of Biogenesis of lysosomal organelles complex 2

Basic information

Region (hg38): 10:102065349-102068036

Links

ENSG00000166189NCBI:79803OMIM:607522HGNC:18817Uniprot:Q86YV9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Hermansky-Pudlak syndrome 6 (Strong), mode of inheritance: AR
  • Hermansky-Pudlak syndrome without pulmonary fibrosis (Supportive), mode of inheritance: AR
  • Hermansky-Pudlak syndrome 6 (Definitive), mode of inheritance: AR
  • Hermansky-Pudlak syndrome 6 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Hermansky-Pudlak syndrome 6ARAllergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; OphthalmologicPrevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Prompt treatment of pulmonary infections (as well as avoidance of cigarette smoke) to maximize pulmonary function is indicated, including influenza and pneumococcus vaccination; Surveillance related to ophthalmologic, gastrointestinal, and other manifestations has been recommended in all individuals with HPSAllergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pulmonary12548288; 20301464; 27225848

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HPS6 gene.

  • not provided (53 variants)
  • Hermansky-Pudlak syndrome 6 (11 variants)
  • Hermansky-Pudlak syndrome (5 variants)
  • HPS6-related disorder (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HPS6 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
11
clinvar
170
clinvar
7
clinvar
188
missense
1
clinvar
2
clinvar
215
clinvar
8
clinvar
1
clinvar
227
nonsense
21
clinvar
8
clinvar
29
start loss
1
clinvar
1
frameshift
33
clinvar
12
clinvar
2
clinvar
47
inframe indel
4
clinvar
4
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 55 22 233 178 9

Highest pathogenic variant AF is 0.0000525

Variants in HPS6

This is a list of pathogenic ClinVar variants found in the HPS6 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-102065470-G-A Hermansky-Pudlak syndrome 6 • not specified • HPS6-related disorder Uncertain significance (Jun 10, 2020)880395
10-102065475-A-G Hermansky-Pudlak syndrome 6 Uncertain significance (Apr 01, 2022)812730
10-102065478-A-T Pathogenic (Jun 09, 2023)3003734
10-102065481-C-T Hermansky-Pudlak syndrome 6 Uncertain significance (Aug 23, 2022)1492067
10-102065485-C-T Inborn genetic diseases Uncertain significance (Jun 06, 2023)2558010
10-102065487-G-A Uncertain significance (Jul 29, 2022)2077948
10-102065489-G-A Likely benign (Sep 21, 2023)2872672
10-102065490-ACT-A Hermansky-Pudlak syndrome 6 Likely pathogenic (Dec 30, 2017)623366
10-102065491-C-T Uncertain significance (Aug 01, 2022)1353976
10-102065498-G-T Likely benign (May 19, 2023)2994227
10-102065500-TG-T Pathogenic (Nov 05, 2023)2693547
10-102065504-C-G HPS6-related disorder Likely benign (Jan 11, 2024)1898652
10-102065504-C-T Likely benign (Apr 14, 2023)2875469
10-102065507-G-A Likely benign (Mar 27, 2023)2995503
10-102065511-CT-GG Uncertain significance (Oct 24, 2022)1918509
10-102065516-C-T Likely benign (Jan 03, 2024)2892950
10-102065517-G-A Uncertain significance (May 06, 2021)1351754
10-102065518-C-G Inborn genetic diseases Uncertain significance (Mar 06, 2023)2494577
10-102065518-C-T Inborn genetic diseases Uncertain significance (Mar 18, 2024)3284742
10-102065519-C-T Likely benign (Aug 02, 2023)755018
10-102065521-T-C Uncertain significance (Jan 15, 2022)2083194
10-102065523-G-GGCGGC Hermansky-Pudlak syndrome • HPS6-related disorder Pathogenic (Jan 24, 2024)1452276
10-102065528-C-T Likely benign (Nov 19, 2023)2904009
10-102065531-G-A Likely benign (Dec 09, 2023)1650834
10-102065544-G-A Inborn genetic diseases Uncertain significance (Aug 16, 2022)2169322

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HPS6protein_codingprotein_codingENST00000299238 12646
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002770.99700000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.02574044031.000.00002354748
Missense in Polyphen108127.60.846391637
Synonymous-1.652201911.150.00001031880
Loss of Function2.611023.70.4210.00000160209

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May regulate the synthesis and function of lysosomes and of highly specialized organelles, such as melanosomes and platelet dense granules (PubMed:17041891). Acts as cargo adapter for the dynein-dynactin motor complex to mediate the transport of lysosomes from the cell periphery to the perinuclear region. Facilitates retrograde lysosomal trafficking by linking the motor complex to lysosomes, and perinuclear positioning of lysosomes is crucial for the delivery of endocytic cargos to lysosomes, for lysosome maturation and functioning (PubMed:25189619). {ECO:0000269|PubMed:17041891, ECO:0000269|PubMed:25189619}.;

Recessive Scores

pRec
0.149

Intolerance Scores

loftool
0.341
rvis_EVS
-1.04
rvis_percentile_EVS
7.71

Haploinsufficiency Scores

pHI
0.101
hipred
Y
hipred_score
0.520
ghis
0.644

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.861

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hps6
Phenotype
immune system phenotype; renal/urinary system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; pigmentation phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
organelle organization;blood coagulation;melanocyte differentiation;lysosome localization;protein localization to membrane
Cellular component
lysosomal membrane;endoplasmic reticulum;membrane;BLOC-2 complex;early endosome membrane
Molecular function
protein binding;Rab GTPase binding;GTP-dependent protein binding